Biohit Group Financial Statement Release 2019
(WorldNews Finland)

Biohit Group Financial Statement Release 2019 Biohit Oyj Financial Statement Release SUMMARY January-December 2019 · Net sales EUR 10.1 million (EUR 9.9 million) · Net sales grew by 1.2% compared to 2018 · Operative EBITDA EUR +0.6 million (EUR -0.1 million)* · Cash at the end of the period EUR 1.3 million (EUR 1.4 million) · Net sales from international operations 96.0% (95.6%) of total net sales · Equity ratio 83.9% (89.2%)** * Biohit Group implemented the IFRS 16 Leases -standard effective from 1 January 2019. This impacted on Operative EBITDA +0.2 million euros in 2019 due to reason that comparative amounts has not been restated. ** The Group`s equity ratio without the impact of the...